XML 26 R5.htm IDEA: XBRL DOCUMENT v3.19.1
Statements of Changes In Shareholders' Equity - USD ($)
$ in Thousands
Share Capital
Additional paid in capital
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2015 $ 1,442 $ (1,442)
Beginning Balance, shares at Dec. 31, 2015 [1] 19,736,264      
CHANGES        
Issuance of ordinary shares to effect reverse recapitalization transaction      
Issuance of ordinary shares to effect reverse recapitalization transaction, shares 35,884,116 [1] 1,733 1,733
Issuance of ordinary shares and warrants $ 4,444 $ 4,444
Issuance of ordinary shares and warrants, shares [1] 15,050,032      
Exercise of options  
Exercise of options, shares 2,392,275 [1]    
Share-based payment 405 $ 405
Share-based payment, shares [1]      
Loss for the year     (1,913) (1,913)
Ending Balance at Dec. 31, 2016 8,024 (3,355) 4,669
Ending Balance, shares at Dec. 31, 2016 [1] 73,062,687      
CHANGES        
Issuance of ordinary shares and warrants   10,745 10,745
Issuance of ordinary shares and warrants, shares [1] 21,027,690      
Exercise of warrants   22,249 22,249
Exercise of warrants, shares [1] 14,496,403      
Exercise of options   641 641
Exercise of options, shares [1] 865,509      
Share-based payment   2,455 2,455
Share-based payment, shares [1] 50,000      
Loss for the year (15,942) (15,942)
Ending Balance at Dec. 31, 2017   44,114 (19,297) 24,817
Ending Balance, shares at Dec. 31, 2017 [1] 109,502,289      
CHANGES        
Issuance of ordinary shares and warrants   11,208 11,208
Issuance of ordinary shares and warrants, shares [1] 21,963,411      
Exercise of warrants   125 125
Exercise of warrants, shares [1] 156,500      
Exercise of options   34 34
Exercise of options, shares [1] 288,204      
Share-based payment   2,040 2,040
Share-based payment, shares [1] 25,000      
Loss for the year     $ (14,657) (14,657)
Ending Balance at Dec. 31, 2018   $ 23,567
Ending Balance, shares at Dec. 31, 2018 131,935,404 [1] 57,521 (33,954)  
[1] Represents the number of shares of the legal acquirer for all periods presented.